Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Lavielle, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 20 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Milligan, G; Kellett, E; Dacquet, C; Dubreuil, V; Jacoby, E; Millan, MJ; Lavielle, G; Spedding, M
      S 14506: novel receptor coupling at 5-HT1A receptors

      NEUROPHARMACOLOGY
    2. Cayatte, AJ; Du, Y; Oliver-Krasinski, J; Lavielle, G; Verbeuren, TJ; Cohen, RA
      The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    3. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. Millan, MJ; Dekeyne, A; Rivet, JM; Dubuffet, T; Lavielle, G; Brocco, M
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    5. Dubuffet, T; Newman-Tancredi, A; Cussac, D; Audinot, V; Loutz, A; Millan, MJ; Lavielle, G
      Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    6. Dubuffet, T; Loutz, A; Lavielle, G
      An efficient large scale synthesis of coumarins by a dealkylative boron-mediated ring closure of 3-(orthomethoxyaryl)propenoic esters.

      SYNTHETIC COMMUNICATIONS
    7. CIMETIERE B; DUBUFFET T; LANDRAS C; DESCOMBES JJ; SIMONET S; VERBEUREN TJ; LAVIELLE G
      NEW TETRAHYDRONAPHTHALENE DERIVATIVES AS COMBINED THROMBOXANE RECEPTOR ANTAGONISTS AND THROMBOXANE SYNTHASE INHIBITORS

      Bioorganic & medicinal chemistry letters
    8. MILLAN MJ; GOBERT A; NEWMANTANCREDI A; AUDINOT V; LEJEUNE F; RIVET JM; CUSSAC D; NICOLAS JP; MULLER O; LAVIELLE G
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    9. MILLAN MJ; SCHREIBER R; DEKEYNE A; RIVET JM; BERVOETS K; MAVRIDIS M; SEBBAN C; MAURELREMY S; NEWMANTANCREDI A; SPEDDING M; MULLER O; LAVIELLE G; BROCCO M
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    10. CAYATTE AJ; DU Y; YAGHOUBI M; OLIVERKRASINSKI J; LAVIELLE G; VERHEUREN TJ; COHEN RA
      THE THROMBOXANE A(2) RECEPTOR ANTAGONIST, S18886, DECREASES ATHEROSCLEROTIC LESIONS AND SERUM INTRACELLULAR ADHESION MOLECULE-1 IN THE APO-E KNOCKOUT MOUSE

      Circulation
    11. VERBEUREN T; DESCOMBES JJ; SIMONET S; DUBUFFET T; LAVIELLE G
      THE TP-RECEPTOR ANTAGONIST S-18886 UNMASKS VASCULAR RELAXATION AND POTENTIATES THE ANTIPLATETLET ACTION OF PGD(2)

      Thrombosis and haemostasis
    12. DUBUFFET T; CIMETIERE B; LAVIELLE G
      A CONVENIENT SYNTHESIS OF 2H-PYRAN-2-ONE DERIVATIVES

      Synthetic communications
    13. NEWMANTANCREDI A; CONTE C; CHAPUT C; VERRIELE L; AUDINOTBOUCHEZ V; LOCHON S; LAVIELLE G; MILLAN MJ
      AGONIST ACTIVITY OF ANTIMIGRAINE DRUGS AT RECOMBINANT HUMAN 5-HT1A RECEPTORS - POTENTIAL IMPLICATIONS FOR PROPHYLACTIC AND ACUTE THERAPY

      Naunyn-Schmiedeberg's archives of pharmacology
    14. AUDINOT V; LOCHON S; NEWMANTANCREDI A; LAVIELLE G; MILLAN MJ
      BINDING PROFILE OF THE NOVEL 5-HT1B 1D RECEPTOR ANTAGONIST, [H-3] GR-125,743, IN GUINEA-PIG BRAIN - A COMPARISON WITH [H-3] 5-CARBOXAMIDOTRYPTAMINE/

      European journal of pharmacology
    15. MILLAN MJ; PEGLION JL; LAVIELLE G; PERRINMONNEYRON S
      5-HT2C RECEPTORS MEDIATE PENILE ERECTIONS IN RATS - ACTIONS OF NOVEL AND SELECTIVE AGONISTS AND ANTAGONISTS

      European journal of pharmacology
    16. VERBEUREN TJ; VALLEZ MO; LAVIELLE G; BOUSKELA E
      ACTIVATION OF THROMBOXANE RECEPTORS AND THE INDUCTION OF VASOMOTION IN THE HAMSTER-CHEEK POUCH MICROCIRCULATION

      British Journal of Pharmacology
    17. DESCOMBES JJ; MENANT Y; LAVIELLE G; VERBEUREN TJ
      BINDING-PROPERTIES OF A POTENT, LONG-ACTING NEW THROMBOXANE RECEPTOR ANTAGONIST, [H-3]S-18886, ON HUMAN, RAT AND DOG PLATELET MEMBRANE

      British Journal of Pharmacology
    18. DUBUFFET T; MULLER O; SIMONET SS; DESCOMBES JJ; LAUBIE M; VERBEUREN TJ; LAVIELLE G
      SYNTHESIS OF NEW 3,4-DISUBSTITUTED PYRROLIDINES AS THROMBOXANE A(2) PROSTAGLANDIN H-2 (TP) RECEPTOR ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    19. VERBEUREN TJ; SIMONET S; DESCOMBES JJ; VALLEZ MO; LAUBIE M; LAVIELLE G
      S-18204 - A NEW POWERFUL TXA(2)-RECEPTOR ANTAGONIST WITH A LONG-DURATION OF ACTION

      Thrombosis and haemostasis
    20. MILLAN MJ; AUDINOT V; BROCCO M; MAURELREMY S; JOLY F; NEWMANTANCREDI A; CANTON H; HAUTEFAYE P; SPEDDING M; MULLER O; LAVIELLE G
      S-16924 - A PYRROLIDINE-SUBSTITUTED BENZODIOXANE WITH HIGHER AFFINITYAT 5-HT1A 2A/2C THAN D2 RECEPTORS, AND AN ATYPICAL ANTIPSYCHOTIC PROFILE IN THE RAT/

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 14:55:25